Vision and Mission
Creating a World Where “Cure” Is the Standard Through SDGs and Medical Innovation
Creating a World Where “Cure” Is the Standard Through SDGs and Medical Innovation
Vision
“Curing the Incurable, Inspiring Global Innovation”
We aim to redefine diabetes as a curable condition and turn this global health challenge into a source of vitality for sustainable local communities. Starting with clinical trials in Palau, we will expand this successful model to the UAE, Japan, and the United States—creating a global positive cycle of SDGs, healthcare, and economic growth.
Mission
Our mission is to redefine what’s possible in global healthcare—by proving a cure for diabetes, building resilient local economies through medical tourism, and pioneering side-effect-free therapies with Biozipcode™ technology.
SDG 3: Scientific Proof of a Diabetes Cure
Using 5-ALA, HDAC inhibitors, and biomarkers, we aim to achieve a diabetes cure and expand from clinical trials in Palau to regulatory approvals in Japan, the UAE, and the U.S.
SDG 8 & 11: Co-creative Local Development
Clinical trials and medical tourism generate jobs and revenue, which are reinvested into resilient, sustainable communities that preserve culture and nature.
SDG 9: Side-effect Free Treatment
Biozipcode™ technology enables side-effect-free drug delivery for diabetes, cancer, and regenerative medicine, forming global innovation clusters across Japan, the U.S., and the UAE.
SDG 17: Transparent Global Partnerships
Companies, universities, hospitals, investors, and policymakers collaborate across countries. Funds and project data are shared transparently via blockchain.
Why Now
By making complete cure the new standard, we can deliver a triple societal return: reduced healthcare costs, improved productivity, and boosted medical tourism.
- Over 590 million people worldwide live with diabetes, with annual healthcare costs exceeding USD 1 trillion.
- Most treatments only manage blood sugar levels, limiting the quality of life (QOL) for patients and families.
- In island nations and developing countries like Palau, limited medical access is worsening health disparities.
- Even in high-income countries (UAE, Japan, the U.S.), diabetes remains feared as an “incurable” disease.
